OHSU Match Day 2024: A career-defining moment for soon-to-be physicians
OHSU Knight Cancer Institute Leadership Announcement
Brian Druker, M.D., and Tom Sellers, Ph.D., M.P.H. (OHSU)
Video download: Meet Dr. Tom Sellers
Tom Sellers, M.D., M.P.H., newly announced director of the OHSU Knight Cancer Institute, introduces himself to the members of the institute. (OHSU).
OHSU Knight Cancer Institute announces leadership transition
Research sheds light on new strategy to treat infertility
Cellular therapy program
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program at the OHSU Knight Cancer Institute. Researchers in the program are looking for new ways to treat lethal cancers such as skin cancer. (OHSU/Kristyna Wentz-Graff)
Richard Maziarz, M.D.
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)
Richard Maziarz, M.D.
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)
Richard Maziarz, M.D.
Richard Maziarz, M.D., medical director of the adult blood and marrow stem cell transplant and cellular therapy program in the OHSU Knight Cancer Institute. (OHSU/Kristyna Wentz-Graff)
OHSU ofrece un nuevo tratamiento para un tipo mortal de cáncer de piel
Dr. Richard Maziarz, director médico del programa de trasplante de adultos de células madre y sangre y terapia celular en OHSU Knight Cancer Institute. Los investigadores del programa están buscando nuevas formas de tratar cánceres letales como el cáncer de piel. (OHSU/Kristyna Wentz-Graff)